Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Acerus Pharmaceuticals Corp (ASPCF)

Acerus Pharmaceuticals Corp (ASPCF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,695
  • Shares Outstanding, K 7,708
  • Annual Sales, $ -4,130 K
  • Annual Income, $ -33,820 K
  • 60-Month Beta 0.69
  • Price/Sales 0.56
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ASPCF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.57
  • Most Recent Earnings $-0.54 on 11/14/22
  • Next Earnings Date 03/13/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2199 unch
on 01/12/23
0.5579 -60.58%
on 12/28/22
-0.6301 (-74.13%)
since 11/29/22
3-Month
0.2199 unch
on 01/12/23
1.2616 -82.57%
on 10/19/22
-1.1036 (-83.38%)
since 09/30/22
52-Week
0.2199 unch
on 01/12/23
8.1600 -97.31%
on 03/18/22
-6.4601 (-96.71%)
since 01/12/22

Most Recent Stories

More News
Acerus Reports Second Quarter 2022 Financial Results

TORONTO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported its...

ASP.TO : 0.3600 (unch)
ASPCF : 0.2199 (-39.90%)
Acerus Announces Amendments to Loan Facility and Promissory Note Due to Former Serenity Shareholders

TORONTO, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced that it...

ASP.TO : 0.3600 (unch)
ASPCF : 0.2199 (-39.90%)
Acerus to Report Q2-2022 Financial Results and Host Investor Call

TORONTO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its second quarter 2022 financial and...

ASP.TO : 0.3600 (unch)
ASPCF : 0.2199 (-39.90%)
Acerus Announces Voting Results for the 2022 Annual Meeting

TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus”) (TSX: ASP; OTCQB: ASPCF) today announced the voting results from...

ASP.TO : 0.3600 (unch)
ASPCF : 0.2199 (-39.90%)
Acerus Announces Amendments to Loan Facility

TORONTO, June 24, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced that it...

ASP.TO : 0.3600 (unch)
ASPCF : 0.2199 (-39.90%)
Acerus Announces Amendment and Restatement of the Promissory Note Related to the Up-Front Fee Payable to Former Serenity Securityholders

TORONTO, June 07, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCD) today announced that it...

ASP.TO : 0.3600 (unch)
ASPCF : 0.2199 (-39.90%)
Acerus Reports First Quarter 2022 Financial Results

TORONTO, May 10, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported its...

ASP.TO : 0.3600 (unch)
ASPCF : 0.2199 (-39.90%)
Acerus Announces Completion of Share Consolidation

TORONTO, April 26, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) announced that further...

ASP.TO : 0.3600 (unch)
ASPCF : 0.2199 (-39.90%)
Acerus Announces Share Consolidation

TORONTO, April 19, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced that...

ASP.TO : 0.3600 (unch)
ASPCF : 0.2199 (-39.90%)
Acerus Announces Amendments to Loan Facility

TORONTO, March 31, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced that it...

ASP.TO : 0.3600 (unch)
ASPCF : 0.2199 (-39.90%)

Business Summary

Acerus Pharmaceuticals Corporation is a pharmaceutical company. The company is focused on the development, manufacture, marketing and distribution of branded products which improve the patient experience. The company's product include ESTRACE(R) which provides symptomatic relief of menopausal symptoms...

See More

Key Turning Points

3rd Resistance Point 0.2199
2nd Resistance Point 0.2199
1st Resistance Point 0.2199
Last Price 0.2199
1st Support Level 0.2199
2nd Support Level 0.2199
3rd Support Level 0.2199

See More

52-Week High 8.1600
Fibonacci 61.8% 5.1269
Fibonacci 50% 4.1899
Fibonacci 38.2% 3.2530
Last Price 0.2199
52-Week Low 0.2199

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar